Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 9 studies | 26% ± 10% | |
ciliated cell | 5 studies | 24% ± 6% | |
epithelial cell | 4 studies | 24% ± 6% | |
glutamatergic neuron | 4 studies | 33% ± 10% | |
microglial cell | 4 studies | 23% ± 6% | |
oligodendrocyte | 4 studies | 21% ± 3% | |
classical monocyte | 3 studies | 24% ± 5% | |
precursor B cell | 3 studies | 19% ± 2% | |
GABAergic neuron | 3 studies | 24% ± 3% | |
macrophage | 3 studies | 20% ± 3% | |
astrocyte | 3 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 863.36 | 180 / 180 | 100% | 22.69 | 430 / 430 |
esophagus | 100% | 996.55 | 1444 / 1445 | 100% | 28.94 | 183 / 183 |
brain | 100% | 1138.29 | 2640 / 2642 | 100% | 20.51 | 705 / 705 |
intestine | 100% | 1173.37 | 966 / 966 | 100% | 27.97 | 526 / 527 |
lung | 99% | 1126.65 | 575 / 578 | 100% | 21.99 | 1151 / 1155 |
breast | 100% | 923.50 | 459 / 459 | 99% | 23.48 | 1107 / 1118 |
thymus | 100% | 2927.94 | 653 / 653 | 98% | 23.70 | 593 / 605 |
stomach | 97% | 576.14 | 347 / 359 | 100% | 29.82 | 285 / 286 |
bladder | 100% | 1117.62 | 21 / 21 | 96% | 19.35 | 485 / 504 |
uterus | 100% | 1035.69 | 170 / 170 | 96% | 14.67 | 441 / 459 |
skin | 100% | 1766.22 | 1808 / 1809 | 95% | 25.24 | 449 / 472 |
prostate | 100% | 760.93 | 245 / 245 | 95% | 11.70 | 475 / 502 |
pancreas | 96% | 550.02 | 315 / 328 | 96% | 11.32 | 171 / 178 |
kidney | 100% | 762.37 | 89 / 89 | 90% | 14.44 | 811 / 901 |
adrenal gland | 100% | 1185.93 | 257 / 258 | 69% | 5.79 | 159 / 230 |
liver | 96% | 455.55 | 216 / 226 | 71% | 6.83 | 289 / 406 |
adipose | 100% | 970.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.14 | 29 / 29 |
muscle | 100% | 1565.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1014.99 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1015.73 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1365.85 | 913 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 15.79 | 43 / 45 |
heart | 93% | 633.33 | 799 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 10.20 | 67 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006338 | Biological process | chromatin remodeling |
GO_0044726 | Biological process | epigenetic programing of female pronucleus |
GO_0071514 | Biological process | genomic imprinting |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000786 | Cellular component | nucleosome |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0032452 | Molecular function | histone demethylase activity |
GO_0071949 | Molecular function | FAD binding |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0140682 | Molecular function | FAD-dependent H3K4me/H3K4me3 demethylase activity |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | KDM1B |
Protein name | AOF1 protein (Lysine demethylase 1B) Lysine-specific histone demethylase 2 (EC 1.14.99.66) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 1B) Lysine demethylase 1B |
Synonyms | AOF1 LSD2 C6orf193 |
Description | FUNCTION: Histone demethylase that demethylates 'Lys-4' of histone H3, a specific tag for epigenetic transcriptional activation, thereby acting as a corepressor. Required for de novo DNA methylation of a subset of imprinted genes during oogenesis. Acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed. Demethylates both mono- and di-methylated 'Lys-4' of histone H3. Has no effect on tri-methylated 'Lys-4', mono-, di- or tri-methylated 'Lys-9', mono-, di- or tri-methylated 'Lys-27', mono-, di- or tri-methylated 'Lys-36' of histone H3, or on mono-, di- or tri-methylated 'Lys-20' of histone H4. Alone, it is unable to demethylate H3K4me on nucleosomes and requires the presence of GLYR1 to achieve such activity, they form a multifunctional enzyme complex that modifies transcribed chromatin and facilitates Pol II transcription through nucleosomes . . |
Accessions | Q08EI0 ENST00000449850.2 ENST00000297792.9 [Q8NB78-2] ENST00000650836.2 [Q8NB78-1] ENST00000546309.6 H0Y6H0 Q8NB78 |